Vir Biotechnology, Inc.: accounts_receivable
| Value | {"amount": 1223161000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-03-31) |
| Status | current |
| Entity | Vir Biotechnology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c40748ab-7795-4858-8620-6149d9a617f4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-007811Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001706431/accounts-receivable/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c40748ab-7795-4858-8620-6149d9a617f4
History
- no predecessors — first report